Survival data from patients with advanced or metastatic renal cell carcinoma in routine practice differs significantly from clinical trial data – Analyses from the German clinical RCC Registry. 7. Juni 2015 Marschner, N., Müller, L., Staehler, M., Nusch, A., Münz, M., Koska, M., Jänicke, M., Goebell, P., 2015. Oncol Res Treat 38 (suppl.5)(V674), 204. doi:10.1159/000439070 Abstract Download Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study. Marschner, N., Arnold, D., Engel, E., Hutzschenreuter, U., Rauh, J., Freier, W., Hartmann, H., Frank, M., Jänicke, M., 2015. Clinical Epidemiology 7, 295–303. doi:10.2147/CLEP.S73857… Weiterlesen No impact of increasing symptom burden on quality of life? – Longitudinal data from the German MaLife-Project on patients receiving monochemo- and endocrine treatment for metastatic breast cancer. Marschner, N., Nusch, A., Decker, T., Münz, M., Kruggel, L., Jänicke, M., 2015. Oncol Res Treat 38 (suppl 5)(V670), 202. doi:10.1159/00043907… Weiterlesen